The Food and Drug Administration recently granted fast-track status to the new immunotherapy agent, Virulizin developed by Lorus Therapeutics for the treatment of advanced pancreatic cancer. The designation of fast-track status fastens the review process of an agent prior to approval and is intended for life-threatening diseases. Virulizin is an agent that stimulates the body?s immune system to fight cancer. Virulizin is isolated from bovine bile and is thought to produce anti-cancer ef...
| Currently you cannot purchase Virulixin as it might be not available for sale online or on local pharmacy. Subscribe below and we will inform you where and when you can order Virulixin |
| Virulixin Availability Subscription Form |
|
| |
| Note: We will email you when Virulixin is available for sale online or in pharmacy in your country. |
|
|
|
|